Literature DB >> 14741618

Nodule formation and mineralisation of human primary osteoblasts cultured on a porous bioactive glass scaffold.

Julie Elizabeth Gough1, Julian R Jones, Larry L Hench.   

Abstract

The aim of this study was to analyse human osteoblast responses to a porous bioactive glass scaffold. It was hypothesised that osteoblasts would attach, proliferate and form mineralised nodules in response to culture on the bioactive glass. As dissolution products are a key feature of bioactive glasses, this was measured by inductively coupled plasma optical emission spectroscopy to determine effects of both the glass surface and ion release. Osteoblasts attached and proliferated on the foams as demonstrated by scanning electron microscopy. Nodule formation was also observed in the pores of the glass and also in conditioned medium containing dissolution products at certain concentrations and these nodules were shown to be mineralised by alizarin red staining. Undiluted dissolution products from the foams however caused significant apoptosis suggesting an ion concentration dependent response.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14741618     DOI: 10.1016/j.biomaterials.2003.07.001

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  43 in total

Review 1.  Stereolithographic bone scaffold design parameters: osteogenic differentiation and signal expression.

Authors:  Kyobum Kim; Andrew Yeatts; David Dean; John P Fisher
Journal:  Tissue Eng Part B Rev       Date:  2010-10       Impact factor: 6.389

2.  Controlling ion release from bioactive glass foam scaffolds with antibacterial properties.

Authors:  Julian R Jones; Lisa M Ehrenfried; Priya Saravanapavan; Larry L Hench
Journal:  J Mater Sci Mater Med       Date:  2006-11-22       Impact factor: 3.896

3.  Mesoporous bioactive glasses: structure characteristics, drug/growth factor delivery and bone regeneration application.

Authors:  Chengtie Wu; Jiang Chang
Journal:  Interface Focus       Date:  2012-03-21       Impact factor: 3.906

4.  Hierarchically engineered fibrous scaffolds for bone regeneration.

Authors:  Nadège Sachot; Oscar Castaño; Miguel A Mateos-Timoneda; Elisabeth Engel; Josep A Planell
Journal:  J R Soc Interface       Date:  2013-08-28       Impact factor: 4.118

5.  Physical and cytocompatibility properties of bioactive glass-polyvinyl alcohol-sodium alginate biocomposite foams prepared via sol-gel processing for trabecular bone regeneration.

Authors:  Ruchi Mishra; Bikramjit Basu; Ashok Kumar
Journal:  J Mater Sci Mater Med       Date:  2009-12       Impact factor: 3.896

6.  Evaluation of 3D nano-macro porous bioactive glass scaffold for hard tissue engineering.

Authors:  S Wang; M M Falk; A Rashad; M M Saad; A C Marques; R M Almeida; M K Marei; H Jain
Journal:  J Mater Sci Mater Med       Date:  2011-03-29       Impact factor: 3.896

7.  "In vitro" behaviour of adult mesenchymal stem cells of human bone marrow origin seeded on a novel bioactive ceramics in the Ca2SiO4-Ca 3(PO4)2 system.

Authors:  Luis Meseguer-Olmo; Salvador Aznar-Cervantes; Patricia Mazón; Piedad N De Aza
Journal:  J Mater Sci Mater Med       Date:  2012-08-19       Impact factor: 3.896

8.  Tantalum coating on TiO2 nanotubes induces superior rate of matrix mineralization and osteofunctionality in human osteoblasts.

Authors:  Christine J Frandsen; Karla S Brammer; Kunbae Noh; Gary Johnston; Sungho Jin
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2014-01-14       Impact factor: 7.328

9.  In vitro biocompatibility assessment of PHBV/Wollastonite composites.

Authors:  Haiyan Li; Wanying Zhai; Jiang Chang
Journal:  J Mater Sci Mater Med       Date:  2007-06-19       Impact factor: 3.896

10.  A comparison of the in vitro mineralisation and dentinogenic potential of mesenchymal stem cells derived from adipose tissue, bone marrow and dental pulp.

Authors:  O G Davies; P R Cooper; R M Shelton; A J Smith; B A Scheven
Journal:  J Bone Miner Metab       Date:  2014-07-06       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.